Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2161-2025

SafeStar 60A Plus Filter. Bidirectionally breathing system filter. Recall

SafeStar 60A Plus Filter. Bidirectionally breathing system filter.

FDA recall Class I

Ongoing

FDA lists this Class I recall for SafeStar 60A Plus Filter. Bidirectionally breathing system filter.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2161-2025
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Jun 16, 2025
FDA report date
Aug 6, 2025
Quantity in commerce
374,700 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

SafeStar 60A Plus Filter. Bidirectionally breathing system filter.

Affected model & UDI checker

Search the exact identifiers published for Z-2161-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
MP05795SafeStar 60A Plus Filter. Bidirectionally breathing system filter.Check source noticeNot specified
Not specifiedSafeStar 60A Plus Filter. Bidirectionally breathing system filter.Check source notice04048675665786
FDA code information

Model No. MP05795; UDI: 04048675665786; All Lots.

View the original FDA recall notice

Why was this product recalled?

Reports of slow increase of CO2-curve when gas sample is taken from the gas sampling port of filters.

What actions did Draeger, Inc. take?

An initial Urgent Medical Device Recall notification dated June 2025 was mailed to consignees. The notification instructs consignees to not make therapeutic decisions based solely on individual measured values or parameters, regardless of the measuring point and the ventilator or anesthesia machine used. Consignees are to not connect the sample line to the filter sampling port; if an alternative sample port is not feasible, the firm requests that consignees use an alternative filter. All users of affected devices are to be notified of this recall notice and the notice forwarded to customers to which product was further distributed. Consignees are asked to complete and return the provided Response Acknowledgement and Receipt Form. Questions can be directed to Michael Kelhart at 267-664-1131 from 8:00 AM EST to 4:30 PM EST, or by email at mike.kelhart@draeger.com. A second Urgent Medical Device Recall notification dated July 2025 was mailed to consignees. This notification recommends that any unused filters affected by this recall not be used and any unused stock should be removed. Consignees are to contact their local Draeger Representative for information regarding alternatives. Draeger Customer Success can be contacted at 1-800-437-2437 (option 2, option 1) or US-Medical@draeger.com to coordinate return/replacement. This recall notification should be shared with all users and forwarded to where devices were further distributed.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology